Clinical Trial

Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 20, 2024 (before its estimated December 20, 2024 completion). Its status may not reflect the trial's current state.
Summary
Along with the current clinical trial, the efficacy and safety of ticagrelor and aspirin administered within the first 24 hours of first-ever ischemic stroke compared to cilostazol and aspirin were assessed through NIHSS, mRS, and possible adverse effects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-23.
Trial Details
NCT Number NCT06196047
Lead Sponsor Kafrelsheikh University
Conditions Ischemic Stroke
Enrollment 900 participants
Start Date 2023-12-01
Primary Completion 2024-12-20 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-20